IRIS
PERRIS, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.006
AS - Asia 7.792
EU - Europa 4.340
SA - Sud America 1.085
AF - Africa 356
Continente sconosciuto - Info sul continente non disponibili 230
OC - Oceania 7
Totale 21.816
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.799
SG - Singapore 2.851
CN - Cina 2.047
VN - Vietnam 1.167
IT - Italia 876
BR - Brasile 837
IE - Irlanda 830
SE - Svezia 669
HK - Hong Kong 591
FI - Finlandia 408
TR - Turchia 375
DE - Germania 348
NL - Olanda 275
FR - Francia 265
ZA - Sudafrica 264
BD - Bangladesh 258
UA - Ucraina 234
GB - Regno Unito 134
CA - Canada 109
AR - Argentina 95
RU - Federazione Russa 75
IN - India 72
JP - Giappone 60
IQ - Iraq 50
MX - Messico 44
CO - Colombia 36
EC - Ecuador 36
PH - Filippine 34
AT - Austria 30
KR - Corea 30
BE - Belgio 29
VE - Venezuela 29
PK - Pakistan 28
BG - Bulgaria 27
CZ - Repubblica Ceca 26
IR - Iran 25
ID - Indonesia 23
MA - Marocco 23
EE - Estonia 19
PL - Polonia 19
UZ - Uzbekistan 19
CL - Cile 18
ES - Italia 17
TH - Thailandia 16
PY - Paraguay 15
MY - Malesia 14
TN - Tunisia 14
JO - Giordania 13
RO - Romania 13
DZ - Algeria 12
SA - Arabia Saudita 12
KZ - Kazakistan 11
NP - Nepal 11
AE - Emirati Arabi Uniti 10
JM - Giamaica 10
LB - Libano 10
CR - Costa Rica 9
TW - Taiwan 9
AZ - Azerbaigian 8
CH - Svizzera 8
EG - Egitto 8
LT - Lituania 8
PE - Perù 8
CI - Costa d'Avorio 7
IL - Israele 7
AU - Australia 6
PA - Panama 6
PT - Portogallo 6
UY - Uruguay 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
HN - Honduras 5
PS - Palestinian Territory 5
XK - ???statistics.table.value.countryCode.XK??? 5
BF - Burkina Faso 4
BH - Bahrain 4
EU - Europa 4
KE - Kenya 4
KG - Kirghizistan 4
NG - Nigeria 4
OM - Oman 4
AL - Albania 3
BY - Bielorussia 3
ET - Etiopia 3
GE - Georgia 3
HU - Ungheria 3
KW - Kuwait 3
LK - Sri Lanka 3
LY - Libia 3
NI - Nicaragua 3
QA - Qatar 3
SC - Seychelles 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BW - Botswana 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
Totale 21.562
Salva come PNG Salva come JPEG
Città #
Singapore 1.257
San Jose 958
Dublin 830
Chandler 769
Ashburn 737
Hong Kong 566
Santa Clara 514
Beijing 466
Dearborn 424
Ho Chi Minh City 380
Izmir 330
Council Bluffs 323
Nanjing 272
Dallas 261
Jacksonville 260
Boardman 256
Hanoi 250
Johannesburg 247
Princeton 212
Lauterbourg 190
Wilmington 166
Ann Arbor 154
Parma 136
New York 116
Los Angeles 114
Helsinki 87
Shanghai 86
Shenyang 86
Hefei 85
Nanchang 81
San Mateo 81
Buffalo 79
Munich 77
Jinan 73
São Paulo 71
Columbus 70
Hebei 67
Milan 67
Tianjin 57
Sant'Ilario d'Enza 56
Haiphong 53
Tokyo 53
Bologna 52
Da Nang 52
Kunming 52
Seattle 52
Jiaxing 47
Moscow 47
Toronto 47
Marseille 43
Changsha 38
Stockholm 34
Düsseldorf 30
Guangzhou 30
Norwalk 30
Rio de Janeiro 29
Houston 28
Des Moines 27
London 27
Bremen 26
Brussels 26
Frankfurt am Main 25
Phoenix 25
Modena 24
Rome 24
Vienna 24
The Dalles 23
Woodbridge 23
Zhengzhou 23
Atlanta 22
Belo Horizonte 22
Chicago 22
Montreal 22
Biên Hòa 21
Borås 21
Falls Church 21
Florence 21
Turku 21
Brno 20
Brooklyn 20
Hải Dương 20
Amsterdam 19
Baghdad 19
Ningbo 19
Nuremberg 19
Hangzhou 18
Orem 18
Brescia 17
Porto Alegre 17
Tashkent 17
Brasília 16
Haikou 16
Pittsburgh 15
Redondo Beach 15
Curitiba 14
Fremont 14
Taizhou 14
Boston 13
Can Tho 13
Fuzhou 13
Totale 12.884
Salva come PNG Salva come JPEG
Nome #
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 317
MEK1/2 KINASES DISABLE THE TUMOR SUPPRESSOR FUNCTIONS OF NATIVE BCR AND ABL1 KINASES TO IMPAIR ANTICANCER DRUGS’ RESPONSIVENESS IN TKI-RESISTANT PHILADELPHIA POSITIVE LEUKEMIAS 278
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH+-LEUKEMIA 260
A translational perspective of the malignant hematopoietic proteoglycome 203
Pro-apoptotic anti-NG2/CSPG4 monoclonal antibodies for disease therapy 200
Antithetic glypican control of cancer growth and dissemination 186
Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target 174
Proteoglycans in metastasis formation and anti-neoplastic therapeutic approaches 163
Drug resistance in higly aggressive acute leukemias is controlled by de novo espressed NG2 proteoglycan acting via modulation of selected transporters 163
Anticorpo monoclonale per diagnosi e trattamento di tumori canini 160
Prognostic role of XTP1/DEPDC1B and SDP35/DEPDC1A in high grade soft-tissue sarcomas 154
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH plus -LEUKEMIA 153
Differential microRNA expression in osteosarcoma cell with different tumorigenic behaviour 152
Combinare più indizi 152
Amphibian neural crest cell migration on purified extracellular matrix components: a chondroitin sulfate proteoglycan inhibits locomotion on fibronectin substrates 151
Differential distribution of aggrecan isoforms in perineuronal nets of the human cerebral cortex 151
Differential microRNA expression in osteosarcoma cell lines with diverse metastatic potential 148
The NeoMark Project interim results: integration of heterogeneous data for prediction of oral squamous cell cancer (OSCC) recurrence. 147
Risk stratification and prediction of locoregional recurrence in patients affected by oral squamous cell carcinoma (OSCC): the Neomark Project interim results. 146
Antithetic roles of proteoglycans in cancer 144
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral squamous cell cancer (OSCC) recurrence: the NeoMark Project’s first report. 140
Proteoglycans as Potential Markers of the Biological Behaviour of Head and Neck Carcinomas: Interim Results of a Multicenter Italian Project. 137
Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors 137
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral cancer recurrence: the NeoMark Project’s first report. 136
Pro-apoptotic anti-NG2/CSPG4 antibodies and their uses for disease therapy 132
Neurogenic potential of human mesenchymal stem cells revised by time-lapse vide-microscopy and wide scale gene expression profiling 130
Glypican and Syndecan: tumor growth regulators 129
Molecular cloning, sequencing, tissue and developmental expression of mouse cartilage oligomeric matrix protein (COMP) 129
Avian neural crest cell migration is diversely regulated by the two major hyaluronan-binding proteoglycans PG-M/versican and aggrecan. 129
Pro-apoptotic anti-NG2/CSPG4 antibodies and their uses for disease therapy 128
Approaching the Proteoglycome: Molecular interactions of proteoglycans and their functional output 128
An intimate interplay between precocious, migrating pericytes and endothelialcells governs human fetal brain angiogenesis 127
Differential microRNA expression in sarcomas with diverse metastatic potential 127
Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality. 126
Risk stratification and prediction of locoregional recurrence in patients affected by oral squamous cell carcinoma (OSCC): the NeoMark project results. 126
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral squamous cell cancer (OSCC) recurrence: the NeoMark project’s interim results. 125
Differential microRNA expression in osteosarcoma cell lines with diverse metastatic potential. 125
Evaluation of immunohistochemical and biomolecular parameters as markers of the biological behaviour of head and neck carcinomas: preliminary results of a multicenter Italian Project. 125
Differential approach to define MicroRNA expression patterns in osteosarcomas 125
Proteoglycans as potential markers of the biological behaviour of head and neck carcinomas: Interim Results of a Multicenter Italian Project. 124
Bidirectional induction of the cognate receptor-ligand alpha4/VCAM-1 pair defines a novel mechanism of tumor intravasation 124
a4b1/a4b7-mediated interaction of human B cell lymphomas with fibronectin involves recognition of multiple cooperating sites 123
Theranostic impact of NG2/CSPG4 proteoglycan in cancer 123
MMPs and angiogenesis affect the metastatic potential of a human vulvar leiomyosarcoma cell line 123
Drug resistance in highly aggressive acute leukemias is controlled by de novo, expressed NG2 proteoglycan acting via modulation of selected transporters 122
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia 120
Aggrecan is expressed by radial glia in the developing human brain 120
Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets 120
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 120
XHas2 activity is required during somitogenesis and precursor cell migration in Xenopus development 117
Analysis of a novel polylactosamine-containing antigen associated with colon carcinomas. 117
Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm 115
Tunneling nanotubes evoke pericyte/endothelial communication during normal and tumoral angiogenesis 115
Blood clotting in space 113
Analysis of tissue-bound and circulating antigens of the poly-N-lactosamine series in colon carcinomas 112
Interaction between cartilage oligomeric matrix protein and extracellular matrix protein 1 mediates endochondral bone growth 110
Pro-apoptotic anti-NG2/CSPG4 antibodies and their uses in disease therapy 110
Anticorpo biparatopico diretto verso NG2/CSPG4 e i suoi usi 109
Structural and compositional divergencies in the extracellular matrix encountered by neural crest cells in the white mutant axolotl embryo 109
The angiogenic asset of soft tissue sarcomas: A new tool to discover new therapeutic targets 109
Bidirectional induction of the cognate receptor-ligand α4/VCAM-1 pair defines a novel mechanism of tumor intravasation 109
Tumor cell NG2 proteoglycan controls cancer progression through its interaction with host Collagen type VI 107
A novel laminin complex is a potent ligand for human leukocytes 107
Morphogenesis-related distribution of intermediate filaments in developing human mesonephros and metanephros 105
Paving the path for invasion: The polyedric role of LASP1 in cancer 105
Improving fluorescence-based assays for the in vitro analysis of cell adhesion and migration 105
MicroRNA expression patterns in osteosarcomas and their potential role in tumour progression 105
Centrifugal assay for fluorescence-based cell adhesion adapted to the analysis of ex vivo cells and capable of determining relative binding strengths 105
PRO-APOPTOTIC ANTI-NG2/CSPG4 ANTIBODIES AND THEIR USES FOR DISEASE THERAPY 104
Proteoglycans in the control of tumor growth and metastasis formation 104
NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion 103
Influence of Tumor Stroma on the Aggressiveness of Poorly Cohesive Gastric Carcinoma 102
Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts 102
Cell origin of tumours and the persistence of cancer propagatine cells in tumour lesions 102
Role of the 4ß7 integrin in the interaction of murine leukemic cells with fibronectin after the in vivo progression from a T-cell lymphoma to leukemic phenotype 101
Molecular mechanisms of avian neural crest cell migration on fibronectin and laminin 101
MicroRNA cloning and sequencing in osteosarcoma cell lines: Differential role of miR-93 101
Localization and expression of Cartilage Oligomeric Matrix Protein (COMP) by human rheumatoid and osteoarthritic synovium and cartilage 100
Pattern d’espressione di microRNAs in cellule di osteosarcoma ed il loro potenziale ruolo nella progressione tumorale 100
Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP9 99
Collagen type VI in neural crest development: distribution in situ and interaction with cells in vitro 99
Attachment of tumor and normal cell lines to collagen type VI involves recognition of the globular domains 99
Laminin-10 is a primary subendothelial ligand for tumor leukocytes 99
Proteomic and post-proteomic characterization of keratan sulfate-glycanated isoforms of thyroglobulin and transferrin uniquely elaborated by papillary thyroid carcinoma 98
Sonic hedgehog regulates the position of the trigeminal ganglia 98
Embryonic extracellular matrix adsorbed in vivo onto microcarriers induces phenotypic expression in cultured neural crest cells 98
Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis 98
An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis 98
Fluorescence-based assays for in vitro analysis of cell adhesion and migration 97
Instructive induction or permissive activation? Differentiation of ectodermal cells isolated from the axolotl blastula 97
"Destemming" cancer stem cells. 96
Preferential locomotion of leukemic cells towards laminin isoforms 8, and 10 95
MicroRNA expression patterns in osteosarcoma 95
INTEGRATION OF CLINICAL, HISTOPATHOLOGICAL, RADIOLOGICAL AND BIOMOLECULAR DATA FOR PREDICTION OF ORAL CANCER RECURRENCE: THE NEOMARK PROJECT'S FIRST REPORT. 94
Tumour dormancy induced by overexpression of PG-M/versican G1 domain in soft tissue sarcomas 94
Dominant role of the G1 domain of PG-M/Versican in the control of the proliferation-apoptosis balance and invasive capabilities of tumour cells. 93
Fluorescence assays to study cell adhesion and migration in vitro 93
Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof 93
Stimulation of initial neural crest cell migration in the axolotl embryo by tissue grafts and extracellular matrix transplanted on microcarriers 93
Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia 92
Totale 12.504
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.610
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022746 0 0 7 22 15 15 51 109 39 57 79 352
2022/20233.042 422 284 136 229 247 320 13 195 1.049 23 104 20
2023/20241.085 66 101 41 27 122 223 41 76 30 79 58 221
2024/20253.872 89 252 262 194 478 385 129 107 549 397 282 748
2025/20268.083 620 844 902 675 1.180 386 894 337 1.051 563 423 208
2026/20271.062 226 499 337 0 0 0 0 0 0 0 0 0
Totale 21.816